These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22842550)

  • 21. Cell fusion: from hybridoma to dendritic cell-based vaccine.
    Gong J; Koido S; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
    Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ; de Vries IJ; Torensma R; Figdor CG
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic role of dendritic cells in cancer immunotherapy.
    Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M
    Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cell-based strategies: novel perspectives for cancer therapy].
    Simone V; Ciavarella S; D'Oronzo S; Silvestris F
    Recenti Prog Med; 2012 Feb; 103(2):49-55. PubMed ID: 22430747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral immunotherapy: using the tumour against itself.
    Crittenden MR; Thanarajasingam U; Vile RG; Gough MJ
    Immunology; 2005 Jan; 114(1):11-22. PubMed ID: 15606790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hybrid cell vaccination approach to cancer immunotherapy.
    Trefzer U; Herberth G; Sterry W; Walden P
    Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322
    [No Abstract]   [Full Text] [Related]  

  • 29. Dendritic cell-based glioma immunotherapy (review).
    Yamanaka R; Yajima N; Abe T; Tsuchiya N; Homma J; Narita M; Takahashi M; Tanaka R
    Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cell immunotherapy for the treatment of neoplastic disease.
    Decker WK; Xing D; Shpall EJ
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine gene-mediated immunotherapy: current status and future perspectives.
    Jinushi M; Tahara H
    Cancer Sci; 2009 Aug; 100(8):1389-96. PubMed ID: 19459853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell, the immunotherapeutic cell for cancer.
    Nagaraj S; Ziske C; Schmidt-Wolf IG
    Indian J Med Res; 2004 Apr; 119(4):133-8. PubMed ID: 15147117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camouflage and sabotage: tumor escape from the immune system.
    Poschke I; Mougiakakos D; Kiessling R
    Cancer Immunol Immunother; 2011 Aug; 60(8):1161-71. PubMed ID: 21626032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep.
    de Gruijl TD; van de Ven R
    Adv Cancer Res; 2012; 115():147-220. PubMed ID: 23021245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cell vaccination for cancer therapy.
    Nestle FO
    Oncogene; 2000 Dec; 19(56):6673-9. PubMed ID: 11426654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell-based treatment of cancer: closing in on a cellular therapy.
    Valone FH; Small E; MacKenzie M; Burch P; Lacy M; Peshwa MV; Laus R
    Cancer J; 2001; 7 Suppl 2():S53-61. PubMed ID: 11777265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells for specific cancer immunotherapy.
    Meidenbauer N; Andreesen R; Mackensen A
    Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor immunity and immunotherapy.
    Boura P; Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of vaccines against self-antigens: the p53 paradigm.
    Chada S; Mhashilkar A; Roth JA; Gabrilovich D
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.